Crossmark Global Holdings Inc. cut its stake in Synopsys, Inc. (NASDAQ:SNPS - Free Report) by 16.6% in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 8,045 shares of the semiconductor company's stock after selling 1,607 shares during the period. Crossmark Global Holdings Inc.'s holdings in Synopsys were worth $3,450,000 as of its most recent filing with the Securities & Exchange Commission.
Other institutional investors also recently bought and sold shares of the company. Brighton Jones LLC raised its position in Synopsys by 5.7% during the 4th quarter. Brighton Jones LLC now owns 921 shares of the semiconductor company's stock worth $447,000 after buying an additional 50 shares during the last quarter. Proficio Capital Partners LLC raised its position in Synopsys by 47.7% during the 4th quarter. Proficio Capital Partners LLC now owns 796 shares of the semiconductor company's stock worth $386,000 after buying an additional 257 shares during the last quarter. Inceptionr LLC purchased a new position in Synopsys during the 4th quarter worth approximately $246,000. PNC Financial Services Group Inc. raised its position in Synopsys by 2.8% during the 4th quarter. PNC Financial Services Group Inc. now owns 25,418 shares of the semiconductor company's stock worth $12,337,000 after buying an additional 703 shares during the last quarter. Finally, NBT Bank N A NY raised its position in Synopsys by 15.9% during the 4th quarter. NBT Bank N A NY now owns 285 shares of the semiconductor company's stock worth $138,000 after buying an additional 39 shares during the last quarter. 85.47% of the stock is currently owned by institutional investors and hedge funds.
Synopsys Price Performance
NASDAQ:SNPS traded up $14.01 during trading hours on Thursday, hitting $564.96. The company's stock had a trading volume of 546,931 shares, compared to its average volume of 1,282,136. The business's 50-day moving average is $495.39 and its two-hundred day moving average is $479.26. The company has a market capitalization of $87.66 billion, a PE ratio of 40.79, a PEG ratio of 3.64 and a beta of 1.12. The company has a debt-to-equity ratio of 1.01, a quick ratio of 6.85 and a current ratio of 7.02. Synopsys, Inc. has a 52-week low of $365.74 and a 52-week high of $624.80.
Synopsys (NASDAQ:SNPS - Get Free Report) last announced its quarterly earnings results on Wednesday, May 28th. The semiconductor company reported $3.67 earnings per share for the quarter, beating analysts' consensus estimates of $3.40 by $0.27. Synopsys had a return on equity of 17.09% and a net margin of 34.77%. The business had revenue of $1.60 billion during the quarter, compared to analysts' expectations of $1.60 billion. During the same quarter last year, the business posted $3.00 earnings per share. The business's revenue for the quarter was up 10.3% on a year-over-year basis. As a group, research analysts anticipate that Synopsys, Inc. will post 10.64 EPS for the current fiscal year.
Wall Street Analyst Weigh In
A number of equities analysts have issued reports on the stock. Rosenblatt Securities reduced their price target on shares of Synopsys from $660.00 to $625.00 and set a "buy" rating for the company in a research report on Thursday, May 29th. KeyCorp lifted their target price on shares of Synopsys from $540.00 to $610.00 and gave the company an "overweight" rating in a report on Thursday. Needham & Company LLC reaffirmed a "buy" rating and set a $650.00 target price on shares of Synopsys in a report on Thursday, May 29th. Bank of America dropped their price target on shares of Synopsys from $630.00 to $560.00 and set a "buy" rating on the stock in a research note on Wednesday, April 16th. Finally, Mizuho lowered their target price on shares of Synopsys from $650.00 to $600.00 and set an "outperform" rating on the stock in a research note on Tuesday, April 15th. One investment analyst has rated the stock with a hold rating and thirteen have issued a buy rating to the company's stock. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average price target of $612.67.
Get Our Latest Analysis on Synopsys
Insider Activity
In other news, CFO Shelagh Glaser sold 7,310 shares of the firm's stock in a transaction on Friday, June 6th. The stock was sold at an average price of $485.72, for a total value of $3,550,613.20. Following the completion of the transaction, the chief financial officer owned 15,291 shares in the company, valued at $7,427,144.52. This trade represents a 32.34% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, CEO Sassine Ghazi sold 11,366 shares of the firm's stock in a transaction on Monday, June 2nd. The shares were sold at an average price of $457.93, for a total value of $5,204,832.38. Following the completion of the transaction, the chief executive officer owned 71,589 shares of the company's stock, valued at approximately $32,782,750.77. This represents a 13.70% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 27,686 shares of company stock worth $13,001,048 over the last 90 days. 0.62% of the stock is currently owned by corporate insiders.
Synopsys Profile
(
Free Report)
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
Read More

Before you consider Synopsys, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synopsys wasn't on the list.
While Synopsys currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for July 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.